High flow nasal cannula is a good treatment option for COVID-19

doi:10.1016/j.hrtlng.2020.03.018

Comment

. 2020 Sep-Oct;49(5):444-445.

doi: 10.1016/j.hrtlng.2020.03.018. Epub 2020 Apr 11.

High flow nasal cannula is a good treatment option for COVID-19

Shike Geng¹, Qing Mei², Chunyan Zhu², Tianjun Yang², Yun Yang³, Xiaowei Fang², Aijun Pan⁴

Affiliations

¹ Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 23001, China.
² Department of Intensive Care Unit, Division of Life Science and Medicine, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, No.17, Lu Jiang Road, Hefei 23001, China.
³ Department of Intensive Care Unit, Infectious Diseases Branch of Anhui Provincial Hospital, Hefei, Anhui, China.
⁴ Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 23001, China; Department of Intensive Care Unit, Division of Life Science and Medicine, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, No.17, Lu Jiang Road, Hefei 23001, China. Electronic address: aijunpan868@sina.com.

PMID: 32295710
PMCID: PMC7151489
DOI: 10.1016/j.hrtlng.2020.03.018

Comment

High flow nasal cannula is a good treatment option for COVID-19

Shike Geng et al. Heart Lung. 2020 Sep-Oct.

. 2020 Sep-Oct;49(5):444-445.

doi: 10.1016/j.hrtlng.2020.03.018. Epub 2020 Apr 11.

Authors

Shike Geng¹, Qing Mei², Chunyan Zhu², Tianjun Yang², Yun Yang³, Xiaowei Fang², Aijun Pan⁴

Affiliations

¹ Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 23001, China.
² Department of Intensive Care Unit, Division of Life Science and Medicine, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, No.17, Lu Jiang Road, Hefei 23001, China.
³ Department of Intensive Care Unit, Infectious Diseases Branch of Anhui Provincial Hospital, Hefei, Anhui, China.
⁴ Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 23001, China; Department of Intensive Care Unit, Division of Life Science and Medicine, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, No.17, Lu Jiang Road, Hefei 23001, China. Electronic address: aijunpan868@sina.com.

PMID: 32295710
PMCID: PMC7151489
DOI: 10.1016/j.hrtlng.2020.03.018

No abstract available

PubMed Disclaimer

Comment on

An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, García-de-Acilu M, Frat JP, Masclans JR, Ricard JD. Roca O, et al. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. Am J Respir Crit Care Med. 2019. PMID: 30576221

Cited by

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
Procopio G, Cancelliere A, Trecarichi EM, Mazzitelli M, Arrighi E, Perri G, Serapide F, Pelaia C, Lio E, Busceti MT, Pelle MC, Ricchio M, Scaglione V, Davoli C, Fusco P, La Gamba V, Torti C, Pelaia G. Procopio G, et al. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016. Ther Adv Respir Dis. 2020. PMID: 33070706 Free PMC article.
COVID-19 cardiopulmonary resuscitation: Guidelines and modifications.
Kundra P, Vinayagam S. Kundra P, et al. J Anaesthesiol Clin Pharmacol. 2020 Aug;36(Suppl 1):S39-S44. doi: 10.4103/joacp.JOACP_257_20. Epub 2020 Jul 24. J Anaesthesiol Clin Pharmacol. 2020. PMID: 33100644 Free PMC article. Review.
Critical care transport in the time of COVID-19.
Tien H, Sawadsky B, Lewell M, Peddle M, Durham W. Tien H, et al. CJEM. 2020 Sep;22(S2):S84-S88. doi: 10.1017/cem.2020.400. CJEM. 2020. PMID: 32398170 Free PMC article.
Evaluation and Performance of a Positive Airway Pressure Device (CPAP-AirFlife™): A Randomized Crossover Non-Inferiority Clinical Study in Normal Subjects.
Tinoco HA, Perdomo-Hurtado L, Henao-Cruz JA, Escobar-Serna JF, Jaramillo-Robledo O, Aguirre-Ospina OD, Hurtado-Hernández M, Lopez-Guzman J. Tinoco HA, et al. Medicina (Kaunas). 2023 Jul 27;59(8):1372. doi: 10.3390/medicina59081372. Medicina (Kaunas). 2023. PMID: 37629662 Free PMC article. Clinical Trial.
In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65.
Kljakovic Gaspic T, Pavicic Ivelja M, Kumric M, Matetic A, Delic N, Vrkic I, Bozic J. Kljakovic Gaspic T, et al. Life (Basel). 2021 Jul 23;11(8):735. doi: 10.3390/life11080735. Life (Basel). 2021. PMID: 34440479 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization (WHO) WHO statement on cases of COVID-19 surpassing 100 000. Statement. 2020;7 https://www.who.int/news-room/detail/07-03-2020-who-statement-on-cases-o...
1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Published online February 07. - DOI - PMC - PubMed
1. Roca O., Caralt B., Messica J. An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. Am J Respir Care Med. 2019;119(11):1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed
1. Chanques G., Riboulet F., Molinari N. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344–1355. doi: 10.1186/ISRCTN15995925. - DOI - PubMed
1. Dysart Kevin, Miller Thomas L., Wolfson Marla R. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103:1400–1405. doi: 10.1016/j.rmed.2009.04.007. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] World Health Organization (WHO) WHO statement on cases of COVID-19 surpassing 100 000. Statement. 2020;7 https://www.who.int/news-room/detail/07-03-2020-who-statement-on-cases-o...

[2] World Health Organization (WHO) WHO statement on cases of COVID-19 surpassing 100 000. Statement. 2020;7 https://www.who.int/news-room/detail/07-03-2020-who-statement-on-cases-o...

[3] Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Published online February 07. - DOI - PMC - PubMed

[4] Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Published online February 07. - DOI - PMC - PubMed

[5] Roca O., Caralt B., Messica J. An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. Am J Respir Care Med. 2019;119(11):1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed

[6] Roca O., Caralt B., Messica J. An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. Am J Respir Care Med. 2019;119(11):1368–1376. doi: 10.1164/rccm.201803-0589OC. - DOI - PubMed

[7] Chanques G., Riboulet F., Molinari N. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344–1355. doi: 10.1186/ISRCTN15995925. - DOI - PubMed

[8] Chanques G., Riboulet F., Molinari N. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344–1355. doi: 10.1186/ISRCTN15995925. - DOI - PubMed

[9] Dysart Kevin, Miller Thomas L., Wolfson Marla R. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103:1400–1405. doi: 10.1016/j.rmed.2009.04.007. - DOI - PubMed

[10] Dysart Kevin, Miller Thomas L., Wolfson Marla R. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103:1400–1405. doi: 10.1016/j.rmed.2009.04.007. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

High flow nasal cannula is a good treatment option for COVID-19

Affiliations

High flow nasal cannula is a good treatment option for COVID-19

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources